<DOC>
	<DOCNO>NCT00833456</DOCNO>
	<brief_summary>The purpose study monitor general functional change among patient schizophrenia , treat atypical antipsychotic dose daily period 6 months.The primary study objective compare general functioning patient schizophrenia treat Seroquel SR baseline last study visit . The secondary study objective compare general functioning patient schizophrenia treated atypical antipsychotic medicinal product administer daily baseline last study visit , monitor indicator clinical improvement , evaluation patient compliance assessment occurrence adverse effect</brief_summary>
	<brief_title>NIS Observe Improvement Global Assessment Functioning Patients With Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>patient diagnosis schizophrenia , define DSMIVTR patient ' symptom control Seroquel SR start 1 month inclusion patient ' symptom control atypical antipsychotic daily formulation start 1 month inclusion patient treat Seroquel SR antipsychotic 1 month patient prescribe antipsychotic combination pregnant woman woman breastfeed patient treated antipsychotic depot formulation last two month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>schizophrenia</keyword>
	<keyword>Seroquel SR</keyword>
	<keyword>atypical antipsychotic</keyword>
	<keyword>assessment functioning</keyword>
	<keyword>GAF scale</keyword>
</DOC>